← Back to Search

Drug-Eluting Stent

1 for Coronary Artery Disease (ELITE Trial)

N/A
Waitlist Available
Led By Lowell Satler, MD
Research Sponsored by Cordis Corporation
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 12 months post procedure
Awards & highlights

ELITE Trial Summary

This trial compares the safety and effectiveness of two stents for treating coronary artery disease.

Eligible Conditions
  • Coronary Artery Disease

ELITE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~12 months post procedure
This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 months post procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Percentage of Participants Who Experienced Target Lesion Failure (TLF)
Secondary outcome measures
Percentage of Device Success - All CYPHER® Stents Included
Percentage of Device Success - Protocol Definition
Percentage of Lesion Success
+15 more

ELITE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: 1Experimental Treatment1 Intervention
CYPHER® ELITE™ Sirolimus-Eluting Stent System.
Group II: 2Active Control1 Intervention
CYPHER® Bx VELOCITY® Sirolimus-eluting Stent System

Find a Location

Who is running the clinical trial?

Cordis CorporationLead Sponsor
91 Previous Clinical Trials
122,942 Total Patients Enrolled
49 Trials studying Coronary Artery Disease
77,861 Patients Enrolled for Coronary Artery Disease
Lowell Satler, MDPrincipal InvestigatorMedstar Health Research Institute
2 Previous Clinical Trials
678 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems
2008. "Study Comparing the CYPHER® ELITE™ to the CYPHER® Bx VELOCITY® Sirolimus-Eluting Stent Systems". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT00715884.
All > Uti
~40 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top